NCT06839170

Brief Summary

we present FM-IRD(also designated as Retina4IRD), the first foundation model-based AI system specifically designed for genotype diagnosis of IRD by emulating clinician decision-making reasoning process. Retina4IRD is capable of processing multimodal input including color fundus photography (CFP), optical coherence tomography (OCT), and descriptive medical metadata. Trained and validated on genetically confirmed cases from centers across China, South Korea, and Poland, the system generates a ranked list of candidate pathogenic genetic variants. Retina4IRD also can generated attention heatmaps to enhance decision-making interpretability. To validate its clinical impact, we conducted a prospective multicenter RCT involving 295 participants, rigorously assessing Retina4IRD's diagnostic accuracy and real-world utility. This will improve the standardized diagnosis of IRD diseases, effectively transforming the traditional time-consuming and resource-intensive diagnostic pathway into an efficient intelligent workflow

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 21, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

February 27, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2025

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

February 11, 2025

Last Update Submit

March 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The diagnostic accuracy of IRDs

    The top-5 gene mutation prediction accuracy, which will be assessed after all participants of the study have had WES test

    21 days

Secondary Outcomes (1)

  • Quality of the health management strategy

    7 days

Study Arms (2)

Retina4IRD(also designated as FM-IRDs) assisted arm

EXPERIMENTAL

Arm A: In the diagnostic process of IRD, retinal specialists make diagnostic decision with the assistance of FM-IRDs.

Other: FM-IRDs assisted

specialist-only without AI assisted arm

ACTIVE COMPARATOR

Arm B: In the diagnostic process of IRD, retinal specialists make independent decision-making without the assistance of FM-IRDs.

Interventions

A Foundation Model for Assisting the precision Diagnosis of Inherited Retinal Diseases: FM-IRDs

Retina4IRD(also designated as FM-IRDs) assisted arm

without FM-IRDs

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Presenting with clinical features suggestive of suspected IRD based on the initial assessment by the physician

You may not qualify if:

  • Refusal to undergo WES genetic testing.
  • Screening for a history of intraocular surgery in both eyes within the past 6 months;
  • Subjects with severe systemic diseases, intellectual developmental disorders, psychiatric illnesses, etc.
  • Patient data that the investigator deems necessary to exclude.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Shanghai General Hospital, Shanghai Jiao Tong University

Shanghai, 200080, China

Location

Shanghai general hospital

Shanghai, China

Location

Study Officials

  • Xiaodong Sun, PhD

    Shanhai General Hopsital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 11, 2025

First Posted

February 21, 2025

Study Start

February 27, 2025

Primary Completion

June 7, 2025

Study Completion

July 1, 2025

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations